Feb 23 (Reuters) - Adaptive Biotechnologies Corp  ADPT.O :
    * ADAPTIVE BIOTECHNOLOGIES EXPANDS COLLABORATION WITH
LABCORP TO
INCREASE ACCESS TO GROWING RESEARCH AND CLINICAL DIAGNOSTIC
PORTFOLIO
    * ADAPTIVE BIOTECHNOLOGIES CORP - EXPANDED COLLABORATION
INCLUDES
A COMMERCIAL AGREEMENT FOR ADAPTIVE'S CLONOSEQ, IMMUNOSEQ ASSAYS
    * ADAPTIVE BIOTECHNOLOGIES CORP - EXPANDED COLLABORATION
INCLUDES
A LAB SERVICES AGREEMENT FOR ADAPTIVE'S RECENTLY LAUNCHED
T-DETECT COVID TEST
    * ADAPTIVE BIOTECHNOLOGIES CORP - LABCORP'S ONCOLOGY SALES
FORCE
WILL PROMOTE CLONOSEQ AT HEMATOLOGY-ONCOLOGY CLINICS IN U.S.
    * ADAPTIVE BIOTECHNOLOGIES - LABCORP IS PREPARING TO PERFORM
T-DETECT COVID AS A SECONDARY SITE LABORATORY ONCE TEST HAS
RECEIVED EUA FROM FDA

Source text for Eikon:  ID:nGNX3WhWMr 
Further company coverage:  ADPT.O 

 ((Reuters.Briefs@thomsonreuters.com;))